Results 11 to 20 of about 636 (106)
Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing? [PDF]
European Heart Journal Cardiovascular Imaging, 2023 Jesper Møller Jensen, Bjarne Nørgaard
exaly +2 more sources
Device-Associated Thrombus with Watchman FLX Left Atrial Appendage Closure Device: A Report of Two Cases [PDF]
Case, 2023 Alan Vainrib
exaly +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The interrelationships between left atrial appendage (LAA) dimensions and device following implantation are unknown. We aimed to analyze the impact of Watchman device implantation on LAA dimensions following its percutaneous closure and ...
Khalil Mahmoudi +12 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The PINNACLE FLX (Protection Against Embolism for Non‐valvular AF [Atrial Fibrillation] Patients: Investigational Device Evaluation of the Watchman FLX LAA [Left Atrial Appendage] Closure Technology) trial evaluated the safety and efficacy of ...
Shephal K. Doshi +18 more
doaj +1 more source
US Cardiology Review, 2023 Transcatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF.
Chirag Bavishi
doaj +1 more source
Transcatheter Left Atrial Appendage Closure
Methodist DeBakey Cardiovascular Journal, 2023 Atrial fibrillation is the most common arrhythmia worldwide, placing a large population at risk for potentially disabling ischemic strokes, yet an estimated 50% of eligible patients cannot tolerate or are contraindicated to receive oral anticoagulation ...
Gordon X. Wong, Gagan D. Singh
doaj +1 more source
Large Device-Related Thrombus Detected following Symptoms of Transient Ischemic Attack
Case Reports in Cardiology, 2021 As an independent risk factor for stroke, atrial fibrillation has been shown to be associated with a fivefold increase in the cause of embolic stroke in comparison to healthy individuals without atrial fibrillation.
Osayi Lawani, Edward Baptista
doaj +1 more source
Medicina, 2023 Background and Objectives: Percutaneous left-atrial appendage (LAA) occlusion is an important therapeutic option for preventing cardioembolic stroke in patients with non-valvular atrial fibrillation (AF) at high risk of thromboembolic events and with ...
Matteo Bianco +20 more
doaj +1 more source
First clinical experience with new left atrial appendage closure device: WATCHMAN FLX® System
Cardiology Plus, 2016 Background: Percutaneous left atrial appendage closure (LAAC) with WATCHMAN (WM) has been recognized as a new interventional routine, but the development of device is continuing.
Xin Xue +6 more
doaj +1 more source
Automated MSCT Analysis for Planning Left Atrial Appendage Occlusion Using Artificial Intelligence
Journal of Interventional Cardiology, 2022 Background. The number of multislice computed tomography (MSCT) analyses performed for planning structural heart interventions is rapidly increasing. Further automation is required to save time, increase standardization, and reduce the learning curve ...
Kilian Michiels +5 more
doaj +1 more source